The report analyzes and
presents an overview of "
Kinesin Spindle Protein (KSP or Eg5) - Pipeline Review, H1 2016 "
worldwide.
lobal
Markets Directs, Kinesin
Spindle Protein (KSP or Eg5)
- Pipeline Review, H1 2016, provides in depth analysis on Kinesin
Spindle Protein (KSP or Eg5) targeted pipeline therapeutics.
The
report provides comprehensive information on the Kinesin Spindle
Protein (KSP or Eg5), targeted therapeutics, complete with analysis
by indications, stage of development, mechanism of action (MoA),
route of administration (RoA) and molecule type. The report also
covers the descriptive pharmacological action of the therapeutics,
its complete research and development history and latest news and
press releases. Additionally, the report provides an overview of key
players involved in Kinesin Spindle Protein (KSP or Eg5) targeted
therapeutics development and features dormant and discontinued
projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Download
Sample copy of this Report at
Scope
- The report provides a
snapshot of the global therapeutic landscape for Kinesin Spindle
Protein (KSP or Eg5)
- The report reviews Kinesin
Spindle Protein (KSP or Eg5) targeted therapeutics under development
by companies and universities/research institutes based on
information derived from company and industry-specific sources
- The report covers pipeline
products based on various stages of development ranging from
pre-registration till discovery and undisclosed stages
- The report features
descriptive drug profiles for the pipeline products which includes,
product description, descriptive MoA, R&D brief, licensing and
collaboration details & other developmental activities
- The report reviews key
players involved in Kinesin Spindle Protein (KSP or Eg5) targeted
therapeutics and enlists all their major and minor projects
- The report assesses Kinesin
Spindle Protein (KSP or Eg5) targeted therapeutics based on mechanism
of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the
dormant and discontinued pipeline projects
- The report reviews latest
news and deals related to Kinesin Spindle Protein (KSP or Eg5)
targeted therapeutics
Reasons to buy
- Gain strategically
significant competitor information, analysis, and insights to
formulate effective R&D strategies
- Identify emerging players
with potentially strong product portfolio and create effective
counter-strategies to gain competitive advantage
- Identify and understand the
targeted therapy areas and indications for Kinesin Spindle Protein
(KSP or Eg5)
- Identify the use of drugs for
target identification and drug repurposing
- Identify potential new
clients or partners in the target demographic
- Develop strategic initiatives
by understanding the focus areas of leading companies
- Plan mergers and acquisitions
effectively by identifying key players and its most promising
pipeline therapeutics
- Devise corrective measures
for pipeline projects by understanding Kinesin Spindle Protein (KSP
or Eg5) development landscape
- Develop and design
in-licensing and out-licensing strategies by identifying prospective
partners with the most attractive projects to enhance and expand
business potential and scope
Table
of Contents
Table
of Contents 2
List
of Tables 5
List
of Figures 5
Introduction
6
Global
Markets Direct Report Coverage 6
Kinesin
Spindle Protein (KSP or Eg5) Overview 7
Therapeutics
Development 8
Kinesin
Spindle Protein (KSP or Eg5) - Products under Development by Stage of
Development 8
Kinesin
Spindle Protein (KSP or Eg5) - Products under Development by Therapy
Area 9
Kinesin
Spindle Protein (KSP or Eg5) - Products under Development by
Indication 10
Kinesin
Spindle Protein (KSP or Eg5) - Pipeline Products Glance 11
Late
Stage Products 11
Early
Stage Products 12
Kinesin
Spindle Protein (KSP or Eg5) - Products under Development by
Companies 13
Kinesin
Spindle Protein (KSP or Eg5) - Products under Development by
Universities/Institutes 16
Kinesin
Spindle Protein (KSP or Eg5) - Therapeutics Assessment 18
Assessment
by Monotherapy/Combination Products 18
Assessment
by Mechanism of Action 19
Assessment
by Route of Administration 20
Assessment
by Molecule Type 22
Kinesin
Spindle Protein (KSP or Eg5) - Companies Involved in Therapeutics
Development 24
4SC
AG 24
Alnylam
Pharmaceuticals, Inc. 25
Array
BioPharma Inc. 26
BIND
Therapeutics, Inc. 27
Kyowa
Hakko Kirin Co., Ltd. 28
Merck
& Co., Inc. 29
Novartis
AG 30
OncoTherapy
Science, Inc. 31
Kinesin
Spindle Protein (KSP or Eg5) - Drug Profiles 32
4SC-205
- Drug Profile 32
Product
Description 32
Mechanism
Of Action 32
R&D
Progress 32
ALN-VSP
- Drug Profile 34
Product
Description 34
Mechanism
Of Action 34
R&D
Progress 34
BIND-267
- Drug Profile 38
Product
Description 38
Mechanism
Of Action 38
R&D
Progress 38
BQS-481
- Drug Profile 39
Product
Description 39
Mechanism
Of Action 39
R&D
Progress 39
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment